Log in

Bellerophon Therapeutics News Headlines (NASDAQ:BLPH)

$3.43
-0.21 (-5.77 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$3.26
Now: $3.43
$3.67
50-Day Range
$0.28
MA: $0.70
$4.00
52-Week Range
$3.26
Now: $3.43
$11.85
Volume85,419 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Bellerophon Therapeutics (NASDAQ BLPH) News Headlines

Source:
DateHeadline
Short Interest in Bellerophon Therapeutics Inc (NASDAQ:BLPH) Drops By 7.8%Short Interest in Bellerophon Therapeutics Inc (NASDAQ:BLPH) Drops By 7.8%
www.americanbankingnews.com - February 15 at 12:34 PM
Bellerophon Therapeutics Inc (NASDAQ:BLPH) Expected to Announce Earnings of -$1.42 Per ShareBellerophon Therapeutics Inc (NASDAQ:BLPH) Expected to Announce Earnings of -$1.42 Per Share
www.americanbankingnews.com - February 14 at 2:48 PM
Bellerophon Therapeutics Stock Scheduled to Reverse Split on Monday, February 10th (NASDAQ:BLPH)Bellerophon Therapeutics Stock Scheduled to Reverse Split on Monday, February 10th (NASDAQ:BLPH)
www.americanbankingnews.com - February 8 at 10:37 AM
Bellerophon Announces 1-for-15 Reverse Stock SplitBellerophon Announces 1-for-15 Reverse Stock Split
finance.yahoo.com - February 7 at 12:03 PM
Zacks: Bellerophon Therapeutics Inc (NASDAQ:BLPH) Given Consensus Rating of "Strong Buy" by AnalystsZacks: Bellerophon Therapeutics Inc (NASDAQ:BLPH) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - January 30 at 2:51 PM
Bellerophon Therapeutics Inc (NASDAQ:BLPH) Short Interest UpdateBellerophon Therapeutics Inc (NASDAQ:BLPH) Short Interest Update
www.americanbankingnews.com - January 29 at 4:38 AM
Bellerophon Therapeutics, Inc. Common Stock (BLPH) Institutional HoldingsBellerophon Therapeutics, Inc. Common Stock (BLPH) Institutional Holdings
www.nasdaq.com - January 24 at 10:10 PM
Bellerophon Therapeutics Inc (NASDAQ:BLPH) Expected to Post Earnings of -$0.10 Per ShareBellerophon Therapeutics Inc (NASDAQ:BLPH) Expected to Post Earnings of -$0.10 Per Share
www.americanbankingnews.com - January 22 at 10:44 PM
BRIEF-Bellerophon Announces Positive Top-Line Results From Cohort 2 Of Phase 2/3 Study Of InopulseBRIEF-Bellerophon Announces Positive Top-Line Results From Cohort 2 Of Phase 2/3 Study Of Inopulse
www.msn.com - December 17 at 11:01 PM
Bellerophon +36% premarket on positive results from iNO-PF studyBellerophon +36% premarket on positive results from iNO-PF study
seekingalpha.com - December 17 at 1:01 PM
Bellerophon stock is up 35% on hypertension trial dataBellerophon stock is up 35% on hypertension trial data
finance.yahoo.com - December 17 at 1:01 PM
Bellerophon Announces Positive Top-line Results from Cohort 2 of Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung DiseaseBellerophon Announces Positive Top-line Results from Cohort 2 of Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - December 17 at 7:46 AM
Bellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung DiseaseBellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - November 12 at 1:22 PM
Bellerophon Presents New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at Pulmonary Fibrosis Foundation Summit 2019Bellerophon Presents New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at Pulmonary Fibrosis Foundation Summit 2019
finance.yahoo.com - November 7 at 12:08 PM
Bellerophon Therapeutics EPS beats by $0.01Bellerophon Therapeutics EPS beats by $0.01
seekingalpha.com - November 6 at 3:46 PM
Bellerophon Provides Business Update and Reports Third Quarter 2019 Financial ResultsBellerophon Provides Business Update and Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 6 at 3:46 PM
BLPH: More Clinical Data Supports Utility of INOpulse, Near-Term Value-Inflection Opportunities GrowBLPH: More Clinical Data Supports Utility of INOpulse, Near-Term Value-Inflection Opportunities Grow
finance.yahoo.com - October 28 at 2:03 PM
Bellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual MeetingBellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting
finance.yahoo.com - October 23 at 8:59 AM
Bellerophon to Present New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual MeetingBellerophon to Present New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting
finance.yahoo.com - October 14 at 8:31 AM
Bellerophons nitric oxide an Orphan Drug in U.S. for IPFBellerophon's nitric oxide an Orphan Drug in U.S. for IPF
seekingalpha.com - September 16 at 6:17 PM
Bellerophon Receives Orphan Drug Designation for Nitric Oxide in the Treatment of Idiopathic Pulmonary FibrosisBellerophon Receives Orphan Drug Designation for Nitric Oxide in the Treatment of Idiopathic Pulmonary Fibrosis
finance.yahoo.com - September 16 at 6:16 PM
Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceBellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 4 at 9:46 AM
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Insiders Increased Their HoldingsBellerophon Therapeutics, Inc. (NASDAQ:BLPH) Insiders Increased Their Holdings
finance.yahoo.com - August 9 at 8:27 AM
Bellerophon Provides Business Update and Reports Second Quarter 2019 Financial ResultsBellerophon Provides Business Update and Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 8 at 9:15 AM
BLPH: Zacks SCR Initiates Coverage of Bellerophon TherapeuticsBLPH: Zacks SCR Initiates Coverage of Bellerophon Therapeutics
finance.yahoo.com - August 7 at 12:01 AM
Bellerophon Completes Enrollment in Cohort 2 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung DiseaseBellerophon Completes Enrollment in Cohort 2 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - August 1 at 8:53 AM
Bellerophon to Present at the JMP Securities Life Sciences ConferenceBellerophon to Present at the JMP Securities Life Sciences Conference
finance.yahoo.com - June 13 at 12:52 PM
Bellerophon to Host Key Opinion Leader Meeting Focused on Pulmonary Hypertension Associated with Interstitial Lung DiseaseBellerophon to Host Key Opinion Leader Meeting Focused on Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - May 22 at 7:22 PM
Bellerophon Presents Additional Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International ConferenceBellerophon Presents Additional Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference
finance.yahoo.com - May 21 at 7:30 PM
Bellerophon to Present Additional Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International ConferenceBellerophon to Present Additional Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference
finance.yahoo.com - May 13 at 7:59 PM
Bellerophon Provides Business Update and Reports First Quarter 2019 Financial ResultsBellerophon Provides Business Update and Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 9 at 7:50 PM
Bellerophon Therapeutics: 1Q Earnings SnapshotBellerophon Therapeutics: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 7:50 PM
What Kind Of Shareholders Own Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)?What Kind Of Shareholders Own Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)?
finance.yahoo.com - May 3 at 7:20 PM
Bellerophon Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung DiseaseBellerophon Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - April 8 at 7:54 PM
Bellerophon Therapeutics, Inc. Estimate MomentumBellerophon Therapeutics, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 8:06 PM
Did Changing Sentiment Drive Bellerophon Therapeutics’s (NASDAQ:BLPH) Share Price Down A Painful 76%?Did Changing Sentiment Drive Bellerophon Therapeutics’s (NASDAQ:BLPH) Share Price Down A Painful 76%?
finance.yahoo.com - March 18 at 8:05 PM
Bellerophon Therapeutics, Inc. (BLPH)Bellerophon Therapeutics, Inc. (BLPH)
finance.yahoo.com - March 14 at 7:23 PM
Bellerophon Provides Business Update and Reports Fourth Quarter and Full-Year 2018 Financial ResultsBellerophon Provides Business Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
finance.yahoo.com - March 14 at 7:23 PM
Bellerophon Therapeutics: 4Q Earnings SnapshotBellerophon Therapeutics: 4Q Earnings Snapshot
finance.yahoo.com - March 14 at 7:23 PM
Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients  Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients  
finance.yahoo.com - January 28 at 6:25 PM
Bellerophon closes $7M capital raise; shares up 6% after hoursBellerophon closes $7M capital raise; shares up 6% after hours
seekingalpha.com - January 25 at 6:16 PM
Bellerophon Announces Closing of $7 Million Public Offering of Common StockBellerophon Announces Closing of $7 Million Public Offering of Common Stock
finance.yahoo.com - January 25 at 6:16 PM
Form 424B5 Bellerophon Therapeutics - StreetInsider.comForm 424B5 Bellerophon Therapeutics - StreetInsider.com
www.streetinsider.com - January 23 at 6:30 PM
Bellerophon Therapeutics (BLPH) Prices 10M Share Common Offering at $0.70/Sh - StreetInsider.comBellerophon Therapeutics (BLPH) Prices 10M Share Common Offering at $0.70/Sh - StreetInsider.com
www.streetinsider.com - January 23 at 6:30 PM
Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswireBellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswire
globenewswire.com - January 23 at 6:30 PM
Bellerophon prices $7M stock offering; shares down 25% premarketBellerophon prices $7M stock offering; shares down 25% premarket
seekingalpha.com - January 23 at 8:10 AM
Bellerophon Announces Pricing of $7 Million Public Offering of Common StockBellerophon Announces Pricing of $7 Million Public Offering of Common Stock
finance.yahoo.com - January 23 at 8:10 AM
Bellerophon down 7% after hours on stock offeringBellerophon down 7% after hours on stock offering
seekingalpha.com - January 22 at 6:28 PM
Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common StockBellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 22 at 6:28 PM
Bellerophon Announces Top-line Results from Cohort 1 of the INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary Hypertension Associated with Interstitial Lung DiseaseBellerophon Announces Top-line Results from Cohort 1 of the INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - January 7 at 6:27 PM
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Featured Article: Most Volatile Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel